Read + Share
Amedeo Smart
Independent Medical Education
Trabelsi Grati O, Zemoura L, Nhy C, Daniel C, et al. Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case report. Lung Cancer 2022;174:186-187.PMID: 36156246
Email
LinkedIn
Facebook
Twitter
Privacy Policy